Top Cancer Stocks in China
Browse the largest China companies in the world ranked by their Market Capitalization. Global Cancer Companies in China market cap is $33.55B.
26 Oct 2024, 01:18 UTC
Companies: 37
🇨🇳1 |  | $9.26 | 0.84% | 7.79B | 54.27% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳2 |  | $23.99 | 1.03% | 3.04B | 82.97% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳3 |  | $5.95 | -3.76% | 2.68B | 0.93% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳4 |  | $8.72 | 2.74% | 2.31B | 17.16% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳5 |  | $5.27 | -4.86% | 2.20B | -27.66% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳6 |  | $5.17 | 1.50% | 2.11B | -23.39% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳7 |  | $5.11 | 2.31% | 1.41B | -18.94% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳8 |  | $1.93 | -0.53% | 1.22B | -57.75% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇨🇳9 |  | $2.82 | 0.15% | 1.17B | -52.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳10 | | $1.73 | -14.75% | 1.07B | -59.59% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇨🇳11 |  | $2.58 | -3.27% | 1.03B | -16.46% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳12 |  | $2.18 | -2.34% | 895.93M | -29.64% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳13 |  | $1.01 | -3.24% | 649.18M | -32.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳14 |  | $1.07 | 0.26% | 617.77M | -50.03% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳15 |  | $3.72 | -0.98% | 588.48M | -58.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳16 |  | $0.37 | -5.32% | 586.93M | -29.46% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳17 |  | $0.45 | -4.48% | 463.58M | -52.73% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳18 |  | $1.66 | 1.03% | 439.56M | 2.52% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳19 |  | $0.59 | 0.00% | 427.81M | -24.73% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳20 |  | $3.75 | 4.93% | 371.63M | -48.61% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳21 |  | $3.40 | 1.49% | 349.10M | 269.57% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳22 |  | $0.40 | 0.98% | 256.01M | -15.15% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳23 |  | $0.20 | -6.75% | 250.27M | -33.04% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳24 |  | $0.56 | 0.23% | 219.72M | -74.27% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳25 |  | $0.24 | -2.59% | 186.40M | -4.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳26 |  | $0.34 | -1.11% | 176.27M | -46.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳27 |  | $0.73 | -15.27% | 165.97M | -81.01% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳28 |  | $0.04 | 0.00% | 161.38M | -32.22% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳29 |  | $2.33 | -15.27% | 102.13M | 18.88% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳30 |  | $6.85 | 1.33% | 91.25M | -2.84% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳31 |  | $1.09 | 0.00% | 90.06M | -41.40% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳32 |  | $0.79 | -0.48% | 88.24M | -30.44% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳33 |  | $0.32 | 4.17% | 82.82M | -67.11% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳34 |  | $0.78 | -2.04% | 72.12M | 44.05% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳35 |  | $0.16 | 0.00% | 65.47M | -45.37% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳36 |  | $0.12 | 0.00% | 53.39M | -43.98% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳37 |  | $0.07 | -6.90% | 46.76M | -73.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
